When the CRO and Sponsor Speak the Same Language, Oversight Stops Being a Negotiation
Ed Fowler, Parexel's former Vice President of Operational Excellence, on what shared CTMS infrastructure has changed — and what...
Ed Fowler, Parexel's former Vice President of Operational Excellence, on what shared CTMS infrastructure has changed — and what...
How Ocular engineered a retinal drug program backward from approval, and what that means for every sponsor still designing...
Frank Watanabe turned a clinician's frustration into a regulatory strategy that has now yielded seven approvals for ZORYVE. The...
Manny Vazquez and Denali Rose on why the industry's oldest data-entry problem is finally solvable and why sites have...
A contactless device, 40 countries, and a design philosophy that starts with patients — not compliance checklists The question...
With enrollment complete at 48 centers across three countries, CEO Ted Ruppel and VP of Marketing Mary Dennehy explain...
Princess Máxima Center for Pediatric Oncology is both sponsor and site, and that dual vantage point gives Rinke Riezebos...
Veeva's regulatory and policy leads on AI accountability, FDA uncertainty, and why fragmentation is the real competitive threat
AOP Health's VP of Digital on why platform consolidation has to come before the AI conversation
Medable's Andrew Mackinnon on agentic AI adoption, ontology layers, and why waiting to clean your data may cost you...